undefined undefined
NaN.000
NaN.00%
TradingKey - INTC Q2: Revenue $16.1B (+25% YoY), DCAI $6.3B (+59%), margin 41.8%, EPS $0.42. $20B capital raise. 14A process: Tesla Terafab validation. Long-term CPU contracts (3-5yr). Q3 guide $15.8-16.8B. Technical: $95.68 support, $103 resistance, descending trendline. Aug 26 Deutsche Bank cataly
08-19 00:51
The acquisition continues Medtronic's momentum in driving strategic deals that further build out the company's core franchises. Drawing on Medtronic's 50 years of neuromodulation leadership, including the industry's
05-20 21:17